February 12, 2014 / 3:15 PM / 4 years ago

BRIEF-Vectura says partner Sandoz receives Belgian approval for Airflusal Forspiro

Feb 12 (Reuters) - Vectura Group PLC : * Belgian regulatory authority confirm approval of airflusal forspiro * Partner sandoz has received Belgian marketing authorisation for Airflusal Forspiro for patients with asthma, copd * Receipt of the Belgian marketing authorisation by sandoz triggers a milestone payment to Vectura of E1.5 million * Source text for Eikon: * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below